Cost is often the deciding factor in choosing a GLP-1 medication, and oral options in 2026 span an enormous price range — from as little as $25/month to well over $1,300/month, depending on the drug, your insurance, and where you fill the prescription. Foundayo, the Wegovy pill, and Rybelsus each have different pricing structures shaped by their approval status, manufacturer programs, and how insurers categorize them.
This guide breaks down what each oral GLP-1 actually costs in 2026, how savings cards and Medicare programs affect the price, and how telehealth and discount platforms like GoodRx fit into the picture. As your complete GLP-1 resource — injections and pills alike — WeightLossInjections.com built this cost guide to help you budget accurately before you start treatment.
Key Takeaways
- Foundayo ranges from $25/month with commercial insurance and a savings card to $149-349/month self-pay, with a $50/month Medicare option starting July 1, 2026.
- The Wegovy pill lists around $1,349/month before any savings programs, reflecting its status as a newer, weight-loss-labeled peptide drug.
- Rybelsus lists around $1,000/month but often sees better insurance coverage because it’s an established, FDA-approved diabetes medication.
- GoodRx and manufacturer coupons can meaningfully reduce out-of-pocket costs for all three drugs, especially Foundayo.
- Telehealth providers (Ro, Hims & Hers, LifeMD, Mochi) often bundle consultation and prescription costs, which can change the effective monthly price.
- Insurance coverage for weight-loss-labeled drugs (Foundayo, Wegovy pill) remains less consistent than coverage for diabetes drugs (Rybelsus), even though all three share GLP-1 mechanisms.
Why Oral GLP-1 Pricing Varies So Much
Three factors drive the wide cost range across Foundayo, the Wegovy pill, and Rybelsus: approval recency, labeled indication, and manufacturer pricing strategy. Rybelsus has been on the market since 2019 and is priced and covered like a mature diabetes drug. The Wegovy pill and Foundayo are newer, weight-loss-labeled drugs — a category insurers have historically been slower and less consistent to cover, which is part of why both manufacturers built aggressive savings-card and self-pay programs to make the drugs accessible outside insurance.
Foundayo (Orforglipron) Pricing
Foundayo has the most tiered and — for many patients — most accessible pricing structure of the three oral GLP-1s:
- Commercial insurance + savings card: as low as $25/month
- Self-pay (no insurance): $149-349/month, depending on dose
- Medicare Part D: $50/month through the Medicare GLP-1 Bridge program, effective July 1, 2026
Foundayo is also widely available through GoodRx, where the self-pay price is around $149/month, and through Eli Lilly’s own direct-to-consumer platform, LillyDirect. Retail pharmacies including CVS, Walgreens, Walmart, Kroger, and Amazon Pharmacy all carry it, and telehealth providers such as Ro, Hims & Hers, LifeMD, and Mochi can facilitate a prescription following an online clinical evaluation. For more on how Foundayo works and where to get it, see our complete Foundayo guide.
Wegovy Pill Pricing
The Wegovy pill’s list price is roughly $1,349/month without insurance or savings programs — comparable to what injectable Wegovy has historically listed for. Novo Nordisk offers savings card programs that can reduce this cost significantly for eligible commercially insured patients, though exact savings depend on plan design and eligibility criteria that change periodically. Because the Wegovy pill is labeled specifically for weight loss (plus MACE risk reduction), insurance coverage is inconsistent — some plans exclude weight-loss medications entirely, while others cover them with prior authorization requirements tied to BMI and comorbidity documentation.
Our Top 3 · July 2026
The best GLP-1 providers right now
Independently reviewed. Ranked by price, medication access, provider quality, and patient outcomes.
Renew GLP
Personalized GLP-1, GIP plans: Semaglutide & Tirzepatide.
Medvi
No membership or hidden fees. Everything you need is included.
Trimi
US-licensed clinicians and shipped to your door, from $99/mo.
Rybelsus Pricing
Rybelsus lists around $1,000/month, but its real-world cost to patients is often lower than that of the Wegovy pill or Foundayo self-pay pricing, because Rybelsus benefits from years of established formulary placement as a type 2 diabetes drug. Insurance plans are generally more willing to cover medications for an FDA-approved indication (diabetes) than for an off-label use (weight loss). That means a patient with type 2 diabetes prescribed Rybelsus on-label may have a meaningfully better coverage experience than someone seeking it off-label purely for weight loss — where coverage is far less predictable. See our guide on Rybelsus and off-label weight-loss use for more on that distinction.
Cost Comparison Table
| Drug | List Price (approx.) | Self-Pay Range | Best-Case With Savings | Insurance Coverage Pattern |
|---|---|---|---|---|
| Foundayo (orforglipron) | $149-349/month | $149-349/month | $25/month (commercial + card); $50/month (Medicare, from July 1, 2026) | Improving, weight-loss labeled |
| Wegovy pill | ~$1,349/month | ~$1,349/month | Varies by savings card eligibility | Inconsistent, weight-loss labeled |
| Rybelsus | ~$1,000/month | ~$1,000/month | Varies by plan/copay tier | Generally better (diabetes labeled) |
Prices reflect list and self-pay figures as of mid-2026 and are subject to change. Confirm current pricing with the manufacturer, your pharmacy, or your insurance plan.
GoodRx and Telehealth Pricing Dynamics
GoodRx functions as a discount card that can lower cash prices at participating pharmacies, and it’s particularly impactful for Foundayo, where the platform lists a self-pay price around $149/month — competitive with or better than some insurance copay scenarios for patients without weight-loss drug coverage. GoodRx savings for the Wegovy pill and Rybelsus vary by pharmacy and location and are worth checking directly, since discount pricing changes frequently.
Telehealth providers — including Ro, Hims & Hers, LifeMD, and Mochi — typically bundle a clinical consultation fee with the medication cost, which can make the effective monthly price look different from pharmacy list price. Some telehealth platforms have direct partnerships with manufacturers (such as LillyDirect for Foundayo) that streamline prescribing and fulfillment. When comparing telehealth options, look closely at what’s included — medication only, or medication plus ongoing consultations — before comparing it to a standard retail pharmacy price.
The Bigger Picture: Comparing Oral Costs to Injectable GLP-1s
It’s worth putting oral GLP-1 pricing in context against injectable options, since many patients are weighing both formats. Injectables like Ozempic, Wegovy, Mounjaro, and Zepbound carry their own list prices, savings card programs, and insurance coverage patterns that shift frequently. Some patients also explore compounded semaglutide as a lower-cost alternative when brand-name products aren’t covered, though compounded products come with their own regulatory and quality considerations distinct from FDA-approved medications. Newer injectable agents such as retatrutide and dual-acting drugs built on tirzepatide add further options to the cost-versus-efficacy conversation. In general, oral GLP-1s — particularly Foundayo with its savings-card and Medicare pricing — currently offer some of the lowest realistic out-of-pocket costs in the entire GLP-1 category, provided you have commercial insurance or Medicare eligibility.
How to Minimize Your Out-of-Pocket Cost
- Ask your prescriber about manufacturer savings cards — both Eli Lilly and Novo Nordisk run savings programs for commercially insured patients that can dramatically cut costs
- Check Medicare Part D options if eligible — the Medicare GLP-1 Bridge program brings Foundayo to $50/month starting July 1, 2026
- Compare GoodRx pricing before assuming insurance is your cheapest path, especially for Foundayo
- Confirm your diagnosis code matches the drug’s approved indication — this materially affects whether insurance will cover the prescription, particularly relevant for Rybelsus (diabetes-only) versus off-label weight-loss use
- Ask telehealth providers for an all-in monthly estimate that includes both consultation and medication costs, rather than comparing medication price alone
FAQ
What is the cheapest oral GLP-1 for weight loss?
Foundayo tends to be the most accessible, with pricing as low as $25/month for commercially insured patients using a savings card, or $50/month under the Medicare GLP-1 Bridge program starting July 1, 2026. Self-pay pricing ($149-349/month) is also generally lower than the Wegovy pill’s list price.
Why does the Wegovy pill cost so much more than Rybelsus?
Both use semaglutide, but the Wegovy pill uses a higher 25 mg dose specifically for weight loss and carries newer, weight-loss-specific list pricing (~$1,349/month), while Rybelsus has years of established diabetes-market pricing (~$1,000/month) and generally better insurance coverage tied to its approved diabetes indication.
Does insurance cover Foundayo or the Wegovy pill?
Coverage varies significantly by plan. Both are weight-loss-labeled drugs, and insurance coverage for weight-loss medications remains inconsistent industry-wide, though manufacturer savings cards can reduce out-of-pocket costs considerably for eligible patients.
Is Rybelsus cheaper than the Wegovy pill if I want it for weight loss?
Rybelsus’s list price (~$1,000/month) is lower than the Wegovy pill’s (~$1,349/month), but if prescribed off-label for weight loss, insurance is less likely to cover it, which can offset any list-price advantage. It also produces far less weight loss (~4-6 lbs vs. ~16.6%) since it’s dosed for diabetes, not weight management.
Will Medicare cover Foundayo, the Wegovy pill, or Rybelsus?
Starting July 1, 2026, the Medicare GLP-1 Bridge program offers Foundayo at $50/month. Medicare coverage for the Wegovy pill and Rybelsus depends on your specific Part D plan and the diagnosis associated with your prescription — check with your plan directly for current details.
Medical disclaimer: This article is for informational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations. Foundayo (orforglipron), Wegovy pill (oral semaglutide 25 mg), and Rybelsus (oral semaglutide 3/7/14 mg) are prescription medications with important safety information and contraindications. Discuss any medication decision with a qualified healthcare provider. Content published by WeightLossInjections.com, your complete resource for GLP-1 medications — injections and pills alike.
